Publications

Publications

 

Sorted by date

 

  • Phase 1 studies of personalized neoantigen vaccine TG4050 in ovarian carcinoma (OC) and head and heck carcinoma (HNSCC)
    JP Delord, et al. ASCO 2022 Abstract available on the ASCO website – Download the poster here Poster Presentation
  • Pseudocowpox virus, a novel vector to enhance the therapeutic efficacy of antitumor vaccination

    Rodrigo Nalio Ramos, et al.
    Clinical and Translational Immunology, May 8 2022 – Read the article
    Publication

  • Comprehensive preclinical studies of BT-001: an oncolytic vaccinia virus armed with Treg-depleting @CTLA4 and GM-CSF

    JB Marchand et al.
    AACR 2022
    Read the abstract here – Download the poster here
    Poster Presentation

  • Phase I trials of personalized cancer vaccine TG4050 in surgically treated high-risk head and neck squamous cell carcinoma (HNSCC) and relapsing ovarian cancer (OvC) patients

    MS Block et al.
    AACR 2022
    Read the abstract here – Download the poster here
    Poster Presentation

 

Sorted by product

 

Transgene sa
400 Boulevard Gonthier d’Andernach - Parc d'Innovation - CS80166
67405 Illkirch Graffenstaden Cedex - France |
Tel. : + 33 (0) 3 88 27 91 00

 

© 2021 Transgene - All rights reserved
Terms of use - Credits